Yan Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yan Liu has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Arturo B Ramirez
Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
1 shared publication - Barbara Garvik
Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
1 shared publication - Chang Xu
Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle, WA 98195, USA
1 shared publication - Christian M Loch
Molecular Diagnostics Program, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
1 shared publication - Chu Chen
School of Statistics and Mathematics, Yunnan University of Finance and Economics, Kunming, China
1 shared publication - David R. Doody
Fred Hutchinson Cancer Center, Seattle, WA
1 shared publication
Latest Publications
- Open Access
- 11 June 2010
- Published by Springer Nature in Molecular Cancer
- Vol. 9 (1) , 143
Integrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival
Lymphotropism in oral squamous cell carcinoma (OSCC) is one of the most important prognostic factors of 5-year survival. In an effort to identify genes that may be responsible for the initiation of OSCC lymphotropism, we examined DNA copy number gains and losses and corresponding gene expression changes from tumor cells in metastatic lymph nodes of patients with OSCC.
- 11 June 2010
- Published by Springer Nature in Molecular Cancer
- Vol. 9 (1) , 143
Open AccessIntegrative analysis of DNA copy number and gene expression in metastatic oral squamous cell carcinoma identifies genes associated with poor survival
Lymphotropism in oral squamous cell carcinoma (OSCC) is one of the most important prognostic factors of 5-year survival. In an effort to identify genes that may be responsible for the initiation of OSCC lymphotropism, we examined DNA copy number gains and losses and corresponding gene expression changes from tumor cells in metastatic lymph nodes of patients with OSCC.
- Open Access
- 24 July 2008
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 41
Use of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery
Strategies to discover circulating protein markers of ovarian cancer are urgently needed. We developed a novel technology that permits us to isolate recombinant antibodies directed against the potential serum biomarkers, to facilitate the further development of affinity reagents necessary to construct diagnostic tests.
- 24 July 2008
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 6 (1) , 41
Open AccessUse of cancer-specific yeast-secreted in vivo biotinylated recombinant antibodies for serum biomarker discovery
Strategies to discover circulating protein markers of ovarian cancer are urgently needed. We developed a novel technology that permits us to isolate recombinant antibodies directed against the potential serum biomarkers, to facilitate the further development of affinity reagents necessary to construct diagnostic tests.